Expanding the CRISPR Toolbox with ErCas12a in Zebrafish and Human Cells.


Journal

The CRISPR journal
ISSN: 2573-1602
Titre abrégé: CRISPR J
Pays: United States
ID NLM: 101738191

Informations de publication

Date de publication:
12 2019
Historique:
pubmed: 20 11 2019
medline: 21 7 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

CRISPR and CRISPR-Cas effector proteins enable the targeting of DNA double-strand breaks to defined loci based on a variable length RNA guide specific to each effector. The guide RNAs are generally similar in size and form, consisting of a ∼20 nucleotide sequence complementary to the DNA target and an RNA secondary structure recognized by the effector. However, the effector proteins vary in protospacer adjacent motif requirements, nuclease activities, and DNA binding kinetics. Recently, ErCas12a, a new member of the Cas12a family, was identified in

Identifiants

pubmed: 31742435
doi: 10.1089/crispr.2019.0026
pmc: PMC6919245
doi:

Substances chimiques

CRISPR-Associated Proteins 0
RNA, Guide 0
RNA 63231-63-0
DNA 9007-49-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

417-433

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM063904
Pays : United States
Organisme : NIH HHS
ID : R24 OD020166
Pays : United States

Références

Nat Biotechnol. 2016 Aug;34(8):863-8
pubmed: 27272384
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Nat Biotechnol. 2014 Mar;32(3):267-73
pubmed: 24535568
Genome Biol. 2018 Jun 26;19(1):80
pubmed: 29945655
Nucleic Acids Res. 2017 Nov 2;45(19):11295-11304
pubmed: 28977650
Stem Cells. 2008 Feb;26(2):496-504
pubmed: 18024421
PLoS One. 2013 Jun 28;8(6):e68201
pubmed: 23840834
Blood. 2011 Oct 27;118(17):4599-608
pubmed: 21881051
Nature. 2008 May 22;453(7194):524-8
pubmed: 18432194
Methods Mol Biol. 2012;920:379-91
pubmed: 22941618
Mol Cell. 2017 Apr 20;66(2):221-233.e4
pubmed: 28431230
Nat Biotechnol. 2019 Mar;37(3):276-282
pubmed: 30742127
Nature. 1995 Nov 9;378(6553):150-7
pubmed: 7477317
Genome Biol. 2015 Nov 02;16:218
pubmed: 26521937
BMC Genomics. 2016 Nov 28;17(1):979
pubmed: 27894274
Cell Rep. 2014 Nov 6;9(3):1151-62
pubmed: 25437567
Science. 2018 Apr 27;360(6387):436-439
pubmed: 29449511
Cell. 2015 Oct 22;163(3):759-71
pubmed: 26422227
Methods. 2018 Nov 1;150:11-18
pubmed: 29964176
Nat Biotechnol. 2016 Aug;34(8):869-74
pubmed: 27347757
Nat Biotechnol. 2017 Apr;35(4):347-349
pubmed: 28263296
CRISPR J. 2022 Feb;5(1):123-130
pubmed: 35119294
Trends Genet. 2000 Jun;16(6):276-7
pubmed: 10827456
Mol Ther. 2016 Apr;24(4):678-84
pubmed: 26867951
Nat Methods. 2011 Jul 10;8(8):671-6
pubmed: 21743461
Genes Dev. 1999 Oct 15;13(20):2633-8
pubmed: 10541549
Front Pharmacol. 2018 Jul 12;9:749
pubmed: 30050439
Nature. 2017 Mar 2;543(7643):113-117
pubmed: 28225754
Sci Rep. 2015 Mar 05;5:8841
pubmed: 25740433
Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13904-9
pubmed: 23918387
Cell Rep. 2016 Apr 26;15(4):707-714
pubmed: 27149851
ACS Synth Biol. 2017 May 19;6(5):902-904
pubmed: 28146356
Mol Ther Nucleic Acids. 2018 Mar 2;10:36-44
pubmed: 29499947
Nat Biotechnol. 2014 Dec;32(12):1262-7
pubmed: 25184501
J Biol Chem. 2018 Apr 27;293(17):6611-6622
pubmed: 29500194
Nat Commun. 2014 Nov 20;5:5560
pubmed: 25410609
Proc Natl Acad Sci U S A. 2013 May 7;110(19):7720-5
pubmed: 23610439
Trends Genet. 2016 Sep;32(9):566-575
pubmed: 27450436
Nucleic Acids Res. 2019 May 7;47(8):4169-4180
pubmed: 30892626
Mutat Res. 2015 Oct;780:86-96
pubmed: 26318124
Nat Commun. 2018 May 15;9(1):1911
pubmed: 29765029
Nat Commun. 2018 Sep 7;9(1):3651
pubmed: 30194297
Cell Res. 2017 Jun;27(6):801-814
pubmed: 28524166
PLoS Genet. 2010 Nov 04;6(11):e1001194
pubmed: 21079684
Nat Biotechnol. 2014 Mar;32(3):279-284
pubmed: 24463574
Genome Res. 2014 Jan;24(1):132-41
pubmed: 24253446
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Nat Biotechnol. 2013 Sep;31(9):822-6
pubmed: 23792628
Bio Protoc. 2021 Jul 20;11(14):e4100
pubmed: 34395736
Science. 2013 Feb 15;339(6121):823-6
pubmed: 23287722
PLoS One. 2011 Apr 21;6(4):e18826
pubmed: 21533036
Nat Methods. 2017 Feb;14(2):153-159
pubmed: 27992409
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nat Commun. 2017 Dec 8;8(1):2024
pubmed: 29222508
PLoS Genet. 2018 Sep 12;14(9):e1007652
pubmed: 30208061
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846

Auteurs

Wesley A Wierson (WA)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Brandon W Simone (BW)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Zachary WareJoncas (Z)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Carla Mann (C)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Jordan M Welker (JM)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Bibekananda Kar (B)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Michael J Emch (MJ)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Iddo Friedberg (I)

Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, Iowa.

William A C Gendron (WAC)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Michael A Barry (MA)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Karl J Clark (KJ)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Drena L Dobbs (DL)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Maura A McGrail (MA)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Stephen C Ekker (SC)

Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota.

Jeffrey J Essner (JJ)

Department of Genetics, Development and Cell Biology, Iowa State University, Ames, Iowa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH